The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 17th Edition
Description
The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 17th Edition
Don’t miss out on this essential tool for navigating the evolving IVD landscape.
Kalorama Information's The Worldwide Market for In Vitro Diagnostic (IVD) Tests, now in its 17th edition, is the essential resource for anyone interested in or involved in the IVD industry. This comprehensive report provides reliable estimates, real-world forecasts from 2024 to 2029, and essential insights needed to understand the IVD market in its entirety. With every significant test category covered in detail, it's like having ten market research reports in one comprehensive volume.
Key Features:
- Extensive Coverage: Detailed estimates and forecasts for every significant IVD test category, with chapters on Clinical Chemistry, Hematology, Histology, Molecular, Immunoassay, Infectious Disease, Coagulation, Blood Bank IVD, Point of Care (POC), and more.
- In-Depth Analysis: Based on vendor reporting, interviews, and global activities, this 1,700 page report offers a full assessment of the IVD market.
- Trusted Source: Published since 1999, it’s the most trusted report by top companies in the IVD industry.
- Growth Projections: Market size, future projections, and compound annual growth rates for all test segments through 2029.
- Company Profiles: In-depth profiles of hundreds of companies, including the top 40, covering financial results, product launches, and strategic plans.
- Global Scope: Analysis includes market size for every significant country and major market segments globally. Essential Insights for Business Planning:
- Market Size and Trends: Understand the size and breakdown of IVD market segments.
- Future Projections: Forecasts for where these markets will be in five years.
- Industry Changes: Track the evolution of the IVD market over time.
- Competitive Landscape: Identify key players, mergers, and groundbreaking product launches.
- Strategic Opportunities: Discover growth markets for potential entry or investment. Country-Level Coverage:This report reflects the global scope of the IVD market, covering:
- Regions: US, Europe, Asia Pacific, Latin America, Eastern Europe, Emerging Markets, Rest of World.
- Countries: Germany, UK, France, Spain, Italy, Russia, Netherlands, Turkey, Poland, Canada, China, Japan, Malaysia, Singapore, South Korea, Australia, Saudi Arabia, Brazil, Argentina, Colombia, Chile, Peru, South Africa, and more.
Table of Contents
1700 Pages
- The Worldwide IVD Market, 2019, 2024, and 2029 ($ billions)
- COVID-19 IVD Market, Share by Segment (Immunoassay Lab-Based, Molecular Dx Lab-Based, Point-of-Care), 2024 (%)
- Scope and Methodology
- Size and Growth of the Market
- Market Highlights
- Competitive Picture in IVD
- Finding What You Are Looking For in the 17th Edition
- IVD Landscape
- Report Design
- PAMA and CMS
- Market Analysis of IVD Market Segments
- Top Suppliers and Niche Players
- IVD Companies Mergers & Acquisitions
- Collaboration, Partnership, Alliance Agreements
- Test Services
- Historical IVD Market vs Today
- Point of View
- COVID-19 Impact and Summary
- Background
- Global Population and Aging
- WHO Essential IVD List
- COVID-19
- Emerging and Emerged Markets
- Size and Forecast for the Global IVD Market
- The IVD Market in the United States
- IVD Market in Europe: Growing Markets
- Japan
- Eastern Europe: Growth Region
- China: Current IVD Market
- India: Population and Opportunity
- Rest of Asia
- Brazil
- Mexico
- The Russian Federation
- Canada
- Emerging Markets
- IVD Market Opportunity by Country
- Introduction
- Gene Editing
- Microbiome
- Next Generation Sequencing
- Information Technology Advances and Artificial Intelligence
- AI in Liquid Biopsy
- Exosome Sequencing
- Biotin Interference in Immunoassay Detection Errors
- Traumatic Brain Injury and IVD
- Personalized Medicine
- Telehealth
- Blockchain
- Substance Abuse
- Saliva Testing
- Breath Test Advances
- Micro-Hospital Opportunities
- Climate Change and Infectious Disease
- Kickback Schemes
- Early Sepsis Detection
- Staffing Shortages
- Overview and Trends
- POC Industry Drivers
- POC Industry Challenges
- Regulatory Challenges
- Professional POC
- OTC Self Testing
- Home Collection Trend
- Pregnancy/Fertility Tests
- Colon Cancer Screening
- Lipid Testing
- Drugs of Abuse Testing
- Rapid and POC Infectious Disease Testing
- Diabetes Testing – Blood Glucose Monitoring
- The Major POC Test Players
- Core Lab Overview and Trends
- Connectivity
- Overview of Chemistry Tests
- Market Analysis
- The Commercial Outlook for Chemistry Tests
- Overview and Trends
- Market Analysis
- Mature Assay Segment
- Maturing Immunoassays
- Growth Immunoassays
- Innovating POC
- The Commercial Outlook for Immunoassays
- Overview
- Sample Preparation and Quality Control
- Molecular Evolution
- Major Players
- Market Analysis
- The Commercial Outlook for Molecular Tests
- Overview of Hematology and Trends
- Laboratory-based Hematology Testing
- Decentralized Hematology Testing
- Market Analysis: Leading Suppliers
- The Commercial Outlook for Hematology Tests
- Overview and Trends of Coagulation and Immunohematology Tests
- Special Topics
- Market Analysis
- Lab-based Testing
- Leading Suppliers: Laboratory Systems
- Decentralized Coagulation Testing – Professional Use
- Leading Suppliers: POC Systems
- The Commercial Market for Coagulation Tests
- The Real Impact of Infections
- Microbial Antibiotic Resistance – The Role of Clinical Tests
- Traditional Microbiology and Its Limits
- The New Microbiology - Innovations
- New Infectious Disease Threats
- Market Analysis
- Market Analysis - Traditional Microbiology ID/AST
- Market Analysis - Microbiology Immunoassays
- Market Analysis - Molecular Microbiology
- Mass Spectrometry
- The Future Outlook for Microbiology
- Overview
- Global Blood Safety
- Blood Typing and Grouping Market
- Blood Testing Market
- The Commercial Outlook for Blood Banking Testing
- Overview
- Special Topics
- Market Analysis
- The Commercial Outlook for Histology and Cytology Tests
- Abbott Diagnostics
- Agilent Technologies
- Beckman Coulter / Danaher
- Becton, Dickinson and Company (BD)
- bioMérieux Inc.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation
- Cepheid / Danaher
- Danaher Corporation
- Dexcom
- DiaSorin S.p.A
- Exact Sciences
- Hologic, Inc.
- Illumina
- Instrumentation Laboratory (IL) / Werfen
- Leica Biosystems/Danaher
- Natera
- QuidelOrtho Corporation
- Radiometer A/S / Danaher
- Revvity
- Roche Diagnostics
- Roche Tissue Diagnostics
- Siemens Healthineers (Siemens)
- Sysmex Corporation
- Thermo Fisher Scientific Inc.
- Werfen
- BGI Genomics (formerly Beijing Genome Institute)
- Biocartis
- Diagnostica Stago S.A.S.
- Eiken Chemical Co., Ltd
- Fujirebio Diagnostics, Inc.
- Fulgent Genetics, Inc
- Grifols S.A.
- Guardant Health, Inc.
- Horiba Medical
- Invitae
- Menarini Diagnostics
- Meridian Bioscience, Inc.
- Mindray - Shenzhen Mindray Bio-medical Electronics Co., Ltd.
- Myriad Genetics, Inc.
- Nihon Kohden
- OraSure Technologies, Inc.
- QIAGEN
- Randox Laboratories Ltd.
- Sekisui Diagnostics LLC
- Veracyte, Inc.
- AliveDx
- Cerus Corporation
- AB SCIEX Pte Ltd.
- ARKRAY
- EKF Diagnostics Holdings Plc
- ELITech Group S.A.S.
- Shimadzu Scientific Instruments
- Snibe Co. Ltd., (Shenzhen New Industries Biomedical Engineering Co. Ltd.)
- Tosoh Bioscience
- Trinity Biotech Plc
- Biocept, Inc.
- Biodesix
- Epic Sciences
- Epigenomics AG
- Foundation Medicine, Inc.
- Menarini-Silicon Biosystems
- NeoGenomics
- Ascensia Diabetes Care Holdings AG
- Bigfoot Biomedical Inc. (Abbott)
- Debiotech SA
- Glooko Inc.
- Insulet Corporation
- Lifescan Inc.
- Medtronic plc
- Nemaura Medical Inc.
- Verily Life Sciences LLC
- CellaVision AB
- Masimo Corporation
- Nova Biomedical Corporation (Nova)
- Amoy Diagnostics Co. Ltd.
- Applied Spectral Imaging Inc. (ASI)
- BioGenex Laboratories, Inc.
- BioView Ltd.
- Visiopharm
- Biohit Healthcare
- Biomerica Inc.
- Bio-Techne Corporation
- Eurobio Scientific
- EUROIMMUN AG (Revvity)
- Immunodiagnostic Systems (IDS)
- INOVA Diagnostics, Inc.
- One Lambda, Inc
- Response Biomedical Corp.
- Theradiag
- VolitionRx Limited
- Accelerate Diagnostics, Inc.
- Advanced Biological Laboratories, S.A. (ABL)
- altona Diagnostics
- ArcDia International Oy Ltd.
- BIOFIRE Diagnostics, LLC. (Acquired by bioMérieux)
- COPAN ITALIA S.p.A. and COPAN Diagnostics, Inc.
- Curetis
- Genetic Analysis AS
- Greiner Bio-One International GmbH
- Mast Group
- Mobidiag
- Q-linea AB
- OpGen, Inc.
- Seegene, Inc.
- T2 Biosystems
- Enzo Biochem Inc.
- NanoString Technologies, Inc. (Bruker)
- Pacific Biosciences of California, Inc. (PacBio)
- Standard BioTools
- Takara Bio Inc.
- Vela Diagnostics
- Abingdon Health Ltd.
- binx Health
- Biomeme, Inc.
- Chembio Diagnostic Systems, Inc.
- Co-Diagnostics, Inc.
- Cue Health
- Diazyme
- DNA Electronics Ltd (DNAe)
- DxGen Corp
- Genedrive plc (formerly Epistem Holdings)
- Immunostics, Inc.
- MedMira, Inc.
- QuantuMDx Group, Ltd.
- Rheonix, Inc.
- Berry Genomics Co. ltd.
- CooperGenomics (Division of CooperSurgical)
- INEX Innovate
- Oxford Gene Technology
- Yourgene Health
- 10x Genomics
- Agena Bioscience, Inc.
- Biotype Diagnostic GmbH
- DxTerity Diagnostics Inc.
- Horizon Discovery Group plc
- IncellDx
- LGC SeraCare Life Sciences, Inc.
- PreAnalytiX GmbH
- Precipio, Inc.
- Quanterix Corporation
- Streck Inc.
- 23andMe
- Agendia BV
- Ambry Genetics
- ARUP Laboratories
- Aspira Women’s Health
- BioReference Laboratories
- Biotheranostics
- BluePrint Genetics Oy
- Boston Heart Diagnostics
- CareDx, Inc.
- Predictive Oncology
- Labcorp, Laboratory Corporation of America
- Mayo Clinic Laboratories
- MDxHealth SA
- OPKO Diagnostics
- Quest Diagnostics
- Sonic Healthcare
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
